Cancyte is a company that focuses on developing modern molecular and genomic based diagnostic test that would give us insight (Cyte) into the detection and possible therapies for various types of Cancer (Can) and infectious diseases and hence the name Cancyte has been chosen to represent our interest in creating company with this vison.

​

 

Cancyte has access to senior scientists, Pathologists and Oncologists across the globe and presently setting up world class diagnostics with NABL-ILAC accreditation. We are striving to provide affordable quality molecular diagnostics at customer doorstep with the help of motivated Scientists with various backgrounds.